Business ❯ Pharmaceutical Industry

Market Dynamics

Pricing Strategies Drug Pricing Drug Sales Drug Pricing Strategies Competition Generic Drugs Drug Competition Drug Development Stock Performance Supply Chain

Deloitte Warns GLP-1 Boom Is Inflating Pharma Returns, Concentrating Risk

Heavy bets on obesity drugs increase vulnerability to shocks.

NHS Warns Some Medicines Could Run Out in Days as Hormuz Disruption Bites

Brazil Sets 2026 Medicine Price Caps With Three-Tier Increases Up to 3.81%

India Tightens Oversight of GLP-1 Drugs as Semaglutide Generics Proliferate

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

Generics Flood India After Semaglutide Patent Lapses, Slashing Prices Up to 90%

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

Brazil's Semaglutide Patent Expires Friday, Opening Door to Ozempic Generics

Brazil Nears Semaglutide Patent Expiry as Anvisa Reviews 14 Filings and Novo Nordisk Counters

Warken Moves to Raise Fixed Pharmacy Fee to €9.50 This Spring

UAE Orders Multiple Authorised Agents Per Medicine to Curb Drug Monopolies

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

German Insurer TK Sees Up to €11 Billion Annual Savings From Drug Pricing Reforms

Court Fallout Prompts Change at Cofepris as Víctor Hugo Borja Takes the Helm

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand

Germany Launches Pharma and MedTech Strategy Talks to Tackle Drug Shortages

U.S. Envoy Warns of Pharma Pullout as AstraZeneca Rejects UK Drug-Price Offer